Gene Symbol | Gene ID | Gene Info |
---|---|---|
Crx
|
ENSMUSG00000041578.9 | Crx |
Gsc
|
ENSMUSG00000021095.4 | Gsc |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Crx | chr7_15867824_15867975 | 3503 | 0.136515 | -0.12 | 3.5e-01 | Click! |
Crx | chr7_15867597_15867748 | 3730 | 0.132764 | -0.12 | 3.7e-01 | Click! |
Gsc | chr12_104471272_104472544 | 1422 | 0.281563 | 0.26 | 4.7e-02 | Click! |
Gsc | chr12_104448135_104448365 | 25080 | 0.111924 | 0.19 | 1.4e-01 | Click! |
Gsc | chr12_104447103_104447270 | 26144 | 0.109765 | 0.16 | 2.1e-01 | Click! |
Gsc | chr12_104469900_104470051 | 3355 | 0.179219 | 0.15 | 2.5e-01 | Click! |
Gsc | chr12_104472660_104473686 | 157 | 0.489042 | 0.13 | 3.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_25753741_25754105 | 3.85 |
Myo10 |
myosin X |
944 |
0.64 |
chr1_177444257_177446079 | 3.74 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
230 |
0.9 |
chr8_45507516_45508498 | 3.53 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr6_93911862_93913573 | 3.47 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr13_75089525_75090889 | 3.43 |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
291 |
0.94 |
chr11_95056996_95057781 | 3.26 |
Itga3 |
integrin alpha 3 |
1193 |
0.35 |
chrX_23285148_23285871 | 3.17 |
Klhl13 |
kelch-like 13 |
50 |
0.99 |
chr12_80759551_80760722 | 3.07 |
Ccdc177 |
coiled-coil domain containing 177 |
551 |
0.62 |
chr14_122477033_122477655 | 2.95 |
Zic2 |
zinc finger protein of the cerebellum 2 |
756 |
0.48 |
chr9_49873782_49874337 | 2.87 |
Gm25633 |
predicted gene, 25633 |
48084 |
0.15 |
chr10_90576163_90577493 | 2.81 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
13 |
0.99 |
chr18_25621574_25622506 | 2.79 |
Gm3227 |
predicted gene 3227 |
24550 |
0.24 |
chr14_66344363_66345813 | 2.78 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr4_22485441_22485749 | 2.77 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
2771 |
0.23 |
chr3_17792420_17792571 | 2.76 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1425 |
0.39 |
chr1_41604694_41605241 | 2.76 |
Gm28634 |
predicted gene 28634 |
75424 |
0.12 |
chr19_55897010_55897961 | 2.74 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
824 |
0.72 |
chr8_31917541_31918367 | 2.71 |
Nrg1 |
neuregulin 1 |
288 |
0.81 |
chr17_56241459_56242409 | 2.69 |
A230051N06Rik |
RIKEN cDNA A230051N06 gene |
218 |
0.81 |
chr7_3332929_3333897 | 2.68 |
Cacng7 |
calcium channel, voltage-dependent, gamma subunit 7 |
458 |
0.64 |
chr16_5884597_5886147 | 2.64 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr3_17793835_17795104 | 2.64 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr14_122461803_122462503 | 2.62 |
Zic5 |
zinc finger protein of the cerebellum 5 |
2132 |
0.2 |
chr5_19746876_19747573 | 2.59 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
160294 |
0.04 |
chr3_84219870_84221146 | 2.57 |
Trim2 |
tripartite motif-containing 2 |
337 |
0.91 |
chrX_161925646_161926717 | 2.55 |
Gm15202 |
predicted gene 15202 |
17958 |
0.26 |
chr1_9298603_9300104 | 2.55 |
Sntg1 |
syntrophin, gamma 1 |
71 |
0.97 |
chr10_42581935_42584872 | 2.53 |
Nr2e1 |
nuclear receptor subfamily 2, group E, member 1 |
229 |
0.69 |
chr7_79510881_79511376 | 2.52 |
A330074H02Rik |
RIKEN cDNA A330074H02 gene |
766 |
0.4 |
chrX_60890286_60890534 | 2.50 |
Sox3 |
SRY (sex determining region Y)-box 3 |
3020 |
0.21 |
chr10_120826843_120827480 | 2.45 |
Msrb3 |
methionine sulfoxide reductase B3 |
23307 |
0.12 |
chr7_144238658_144240098 | 2.44 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
653 |
0.8 |
chr15_91017138_91018295 | 2.40 |
Kif21a |
kinesin family member 21A |
32102 |
0.16 |
chr4_122998435_122998747 | 2.40 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
289 |
0.87 |
chrX_60146958_60147936 | 2.38 |
Mcf2 |
mcf.2 transforming sequence |
196 |
0.96 |
chr19_50487798_50488219 | 2.34 |
Gm26629 |
predicted gene, 26629 |
189398 |
0.03 |
chrX_60895147_60896014 | 2.32 |
Gm14662 |
predicted gene 14662 |
1927 |
0.26 |
chr1_109982396_109983459 | 2.32 |
Cdh7 |
cadherin 7, type 2 |
54 |
0.99 |
chr12_49382714_49384085 | 2.27 |
Foxg1 |
forkhead box G1 |
392 |
0.72 |
chr5_144547334_144548656 | 2.27 |
Nptx2 |
neuronal pentraxin 2 |
2093 |
0.41 |
chr1_146494200_146495557 | 2.25 |
Gm29514 |
predicted gene 29514 |
73 |
0.56 |
chr3_37569664_37570157 | 2.25 |
Spata5 |
spermatogenesis associated 5 |
3708 |
0.16 |
chr2_55437909_55438060 | 2.24 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
819 |
0.72 |
chr3_34197711_34199105 | 2.23 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1544 |
0.41 |
chr2_74426676_74427273 | 2.21 |
Lnpk |
lunapark, ER junction formation factor |
106132 |
0.05 |
chr10_42577522_42578917 | 2.20 |
Nr2e1 |
nuclear receptor subfamily 2, group E, member 1 |
2126 |
0.31 |
chr18_25750468_25751272 | 2.19 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chr9_87144314_87145572 | 2.19 |
Mrap2 |
melanocortin 2 receptor accessory protein 2 |
600 |
0.71 |
chr2_38354292_38355594 | 2.18 |
Lhx2 |
LIM homeobox protein 2 |
1141 |
0.41 |
chr7_60449424_60450258 | 2.18 |
Gm30196 |
predicted gene, 30196 |
156637 |
0.03 |
chr13_56258424_56259826 | 2.17 |
Neurog1 |
neurogenin 1 |
6962 |
0.15 |
chr3_84953332_84953942 | 2.16 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
1491 |
0.53 |
chr15_48791303_48792616 | 2.16 |
Csmd3 |
CUB and Sushi multiple domains 3 |
26 |
0.99 |
chr15_25753053_25753722 | 2.15 |
Myo10 |
myosin X |
408 |
0.88 |
chr14_39472202_39472383 | 2.15 |
Nrg3 |
neuregulin 3 |
374 |
0.93 |
chr7_121391567_121393161 | 2.15 |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
74 |
0.93 |
chr4_97582473_97584218 | 2.15 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
1251 |
0.53 |
chr3_8663653_8664237 | 2.13 |
Hey1 |
hairy/enhancer-of-split related with YRPW motif 1 |
2680 |
0.2 |
chr19_47013396_47013844 | 2.12 |
Ina |
internexin neuronal intermediate filament protein, alpha |
1078 |
0.34 |
chrX_93285785_93287303 | 2.08 |
Arx |
aristaless related homeobox |
34 |
0.98 |
chr7_51624664_51625766 | 2.07 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
67 |
0.98 |
chr19_18888677_18889550 | 2.06 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
48476 |
0.16 |
chr9_107378260_107378857 | 2.06 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
21054 |
0.09 |
chr5_115433010_115433546 | 2.06 |
Msi1 |
musashi RNA-binding protein 1 |
114 |
0.91 |
chr5_131531462_131532675 | 2.06 |
Auts2 |
autism susceptibility candidate 2 |
2329 |
0.29 |
chr7_92234907_92236280 | 2.04 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr3_17790150_17790808 | 2.02 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
522 |
0.77 |
chr2_158611997_158612747 | 2.00 |
Gm14205 |
predicted gene 14205 |
552 |
0.57 |
chr7_140080531_140082545 | 1.99 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr9_100046462_100046656 | 1.99 |
4930519F24Rik |
RIKEN cDNA 4930519F24 gene |
22911 |
0.22 |
chr2_80128704_80129752 | 1.99 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
230 |
0.94 |
chr1_88668363_88668968 | 1.99 |
Gm29336 |
predicted gene 29336 |
12357 |
0.16 |
chr6_148358796_148359144 | 1.98 |
Gm44020 |
predicted gene, 44020 |
175 |
0.93 |
chr14_75457045_75457620 | 1.98 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
1350 |
0.5 |
chr2_68365331_68365864 | 1.97 |
Stk39 |
serine/threonine kinase 39 |
922 |
0.69 |
chrX_147552308_147552607 | 1.97 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
1593 |
0.47 |
chrX_93287572_93288147 | 1.96 |
Arx |
aristaless related homeobox |
1349 |
0.5 |
chr10_80298461_80300404 | 1.96 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr1_42711455_42712692 | 1.93 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
1381 |
0.34 |
chr2_62341681_62342220 | 1.89 |
Dpp4 |
dipeptidylpeptidase 4 |
3196 |
0.24 |
chr5_30712882_30713845 | 1.89 |
Dpysl5 |
dihydropyrimidinase-like 5 |
1462 |
0.33 |
chr3_88206822_88208169 | 1.89 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr4_102256022_102256825 | 1.89 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1193 |
0.63 |
chrX_166346283_166346827 | 1.86 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
chr4_25797148_25797299 | 1.86 |
Fut9 |
fucosyltransferase 9 |
2632 |
0.27 |
chr14_100374663_100375528 | 1.85 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr8_55026043_55026811 | 1.83 |
Gm45264 |
predicted gene 45264 |
1974 |
0.25 |
chr10_110454344_110454630 | 1.82 |
Nav3 |
neuron navigator 3 |
1717 |
0.42 |
chr16_94179302_94180102 | 1.81 |
Hlcs |
holocarboxylase synthetase (biotin- [propriony-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) |
4702 |
0.13 |
chr1_194621304_194621650 | 1.81 |
Plxna2 |
plexin A2 |
1652 |
0.38 |
chr15_68930024_68930460 | 1.80 |
Khdrbs3 |
KH domain containing, RNA binding, signal transduction associated 3 |
174 |
0.96 |
chr1_42689823_42691041 | 1.80 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
2661 |
0.19 |
chr12_117988794_117990154 | 1.80 |
Dnah11 |
dynein, axonemal, heavy chain 11 |
70829 |
0.12 |
chr18_81165961_81166641 | 1.79 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69765 |
0.09 |
chr6_138418319_138419180 | 1.79 |
Lmo3 |
LIM domain only 3 |
2703 |
0.27 |
chr7_79504311_79505700 | 1.77 |
Mir9-3 |
microRNA 9-3 |
259 |
0.82 |
chr4_150284018_150284403 | 1.76 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
2398 |
0.24 |
chr7_64503652_64503803 | 1.76 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
1589 |
0.36 |
chr12_35896354_35896707 | 1.74 |
Agr3 |
anterior gradient 3 |
29090 |
0.17 |
chr11_54305526_54305698 | 1.74 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
1410 |
0.34 |
chr2_113217092_113217461 | 1.73 |
Ryr3 |
ryanodine receptor 3 |
180 |
0.96 |
chr13_83713629_83714389 | 1.72 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
7372 |
0.14 |
chr5_76362963_76363559 | 1.72 |
Nmu |
neuromedin U |
527 |
0.71 |
chr5_142812883_142813172 | 1.70 |
Tnrc18 |
trinucleotide repeat containing 18 |
4353 |
0.21 |
chr16_91226312_91227667 | 1.70 |
Olig2 |
oligodendrocyte transcription factor 2 |
1532 |
0.27 |
chr7_144898015_144898977 | 1.69 |
Gm26793 |
predicted gene, 26793 |
1035 |
0.34 |
chr1_154725377_154725528 | 1.69 |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
468 |
0.89 |
chr13_81632543_81633660 | 1.68 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
38 |
0.98 |
chr2_137113966_137114117 | 1.68 |
Jag1 |
jagged 1 |
2603 |
0.39 |
chr10_130279504_130280322 | 1.68 |
Neurod4 |
neurogenic differentiation 4 |
327 |
0.87 |
chr3_68573207_68574269 | 1.67 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chrX_166344665_166345995 | 1.67 |
Gpm6b |
glycoprotein m6b |
488 |
0.85 |
chr2_65846012_65846807 | 1.66 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
554 |
0.79 |
chr1_126737352_126738681 | 1.66 |
Nckap5 |
NCK-associated protein 5 |
174 |
0.97 |
chr4_141601419_141601624 | 1.66 |
Fblim1 |
filamin binding LIM protein 1 |
1489 |
0.27 |
chrX_133681727_133682400 | 1.65 |
Pcdh19 |
protocadherin 19 |
2928 |
0.38 |
chr9_106458457_106458919 | 1.65 |
Pcbp4 |
poly(rC) binding protein 4 |
1707 |
0.17 |
chr6_28828230_28829085 | 1.64 |
Lrrc4 |
leucine rich repeat containing 4 |
1688 |
0.37 |
chr1_92833736_92833887 | 1.64 |
Gpc1 |
glypican 1 |
1842 |
0.21 |
chr2_73572450_73573344 | 1.63 |
Chrna1 |
cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) |
7441 |
0.15 |
chr2_57698968_57699458 | 1.63 |
Gm25388 |
predicted gene, 25388 |
45391 |
0.15 |
chrX_169827749_169828991 | 1.62 |
Mid1 |
midline 1 |
211 |
0.96 |
chr11_96741984_96742848 | 1.62 |
Gm11537 |
predicted gene 11537 |
24386 |
0.11 |
chr14_55057067_55057894 | 1.61 |
Gm20687 |
predicted gene 20687 |
1987 |
0.14 |
chr6_92480350_92481798 | 1.61 |
Prickle2 |
prickle planar cell polarity protein 2 |
318 |
0.93 |
chr1_133183797_133183948 | 1.61 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
2551 |
0.26 |
chr15_25417810_25418559 | 1.60 |
Gm48957 |
predicted gene, 48957 |
3121 |
0.19 |
chr1_16202325_16202476 | 1.60 |
Gm38249 |
predicted gene, 38249 |
8117 |
0.19 |
chr13_81630063_81630959 | 1.60 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
2628 |
0.28 |
chr9_40267946_40268482 | 1.60 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
1003 |
0.43 |
chr4_62207768_62208497 | 1.59 |
Zfp37 |
zinc finger protein 37 |
70 |
0.97 |
chr13_107247429_107247791 | 1.59 |
Gm2726 |
predicted gene 2726 |
32581 |
0.2 |
chr1_41166433_41166721 | 1.58 |
4930448I06Rik |
RIKEN cDNA 4930448I06 gene |
14675 |
0.3 |
chr5_71095703_71096447 | 1.58 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
226 |
0.97 |
chr2_97478080_97479309 | 1.58 |
Lrrc4c |
leucine rich repeat containing 4C |
10605 |
0.3 |
chr9_4794566_4795419 | 1.58 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
527 |
0.88 |
chr8_47241457_47243549 | 1.58 |
Stox2 |
storkhead box 2 |
166 |
0.96 |
chr13_36613015_36613742 | 1.57 |
Gm46409 |
predicted gene, 46409 |
406 |
0.82 |
chr11_77498465_77499189 | 1.55 |
Git1 |
GIT ArfGAP 1 |
264 |
0.85 |
chr17_85607592_85608395 | 1.55 |
Six3 |
sine oculis-related homeobox 3 |
5615 |
0.15 |
chr2_151631540_151632560 | 1.54 |
Snph |
syntaphilin |
421 |
0.78 |
chr17_67290672_67291179 | 1.54 |
Ptprm |
protein tyrosine phosphatase, receptor type, M |
63148 |
0.15 |
chr7_62422629_62423664 | 1.54 |
Gm32061 |
predicted gene, 32061 |
99 |
0.96 |
chrX_57521131_57522140 | 1.53 |
Gpr101 |
G protein-coupled receptor 101 |
17878 |
0.22 |
chr7_10480473_10481196 | 1.53 |
Gm30645 |
predicted gene, 30645 |
11141 |
0.11 |
chr13_36733520_36734450 | 1.53 |
Nrn1 |
neuritin 1 |
492 |
0.77 |
chr9_102545261_102545799 | 1.53 |
Gm25669 |
predicted gene, 25669 |
2236 |
0.18 |
chr17_48932346_48933546 | 1.53 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
567 |
0.85 |
chr10_120035094_120035766 | 1.53 |
Grip1 |
glutamate receptor interacting protein 1 |
42324 |
0.15 |
chr4_109975449_109975858 | 1.53 |
Dmrta2os |
doublesex and mab-3 related transcription factor like family A2, opposite strand |
1838 |
0.36 |
chr7_60170570_60171087 | 1.53 |
Gm7367 |
predicted pseudogene 7367 |
15219 |
0.13 |
chr11_97626854_97627270 | 1.52 |
Epop |
elongin BC and polycomb repressive complex 2 associated protein |
2640 |
0.14 |
chr3_58158331_58159098 | 1.52 |
1700007F19Rik |
RIKEN cDNA 1700007F19 gene |
5093 |
0.2 |
chr12_83044281_83044492 | 1.52 |
Rgs6 |
regulator of G-protein signaling 6 |
2604 |
0.31 |
chr10_22608963_22609246 | 1.52 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
35907 |
0.16 |
chr15_103514667_103515239 | 1.51 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
33 |
0.97 |
chr6_127768524_127769705 | 1.51 |
Prmt8 |
protein arginine N-methyltransferase 8 |
358 |
0.74 |
chr18_29362958_29363281 | 1.50 |
4930527G23Rik |
RIKEN cDNA 4930527G23 gene |
79081 |
0.11 |
chr19_44513226_44513585 | 1.50 |
Wnt8b |
wingless-type MMTV integration site family, member 8B |
3084 |
0.18 |
chr6_94695739_94697689 | 1.49 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
3423 |
0.29 |
chrX_110809955_110811467 | 1.49 |
Gm44593 |
predicted gene 44593 |
1613 |
0.43 |
chr9_91375968_91376231 | 1.48 |
Zic4 |
zinc finger protein of the cerebellum 4 |
2098 |
0.2 |
chr12_72234504_72235243 | 1.48 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr16_77598670_77599917 | 1.48 |
Mir99a |
microRNA 99a |
357 |
0.44 |
chr7_40901304_40901966 | 1.48 |
A230077H06Rik |
RIKEN cDNA A230077H06 gene |
698 |
0.52 |
chr18_60065050_60065533 | 1.48 |
Gm23576 |
predicted gene, 23576 |
109026 |
0.06 |
chr17_85624908_85626448 | 1.48 |
Six3 |
sine oculis-related homeobox 3 |
4647 |
0.16 |
chr9_43070574_43070912 | 1.47 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
28111 |
0.16 |
chr1_42686011_42687379 | 1.47 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr9_102505628_102506765 | 1.47 |
Ky |
kyphoscoliosis peptidase |
446 |
0.76 |
chr14_64591036_64591686 | 1.47 |
Mir3078 |
microRNA 3078 |
176 |
0.84 |
chr11_117101791_117101951 | 1.46 |
Gm11730 |
predicted gene 11730 |
4804 |
0.11 |
chr14_122375388_122376000 | 1.45 |
Gm25464 |
predicted gene, 25464 |
12466 |
0.18 |
chr13_53469792_53470715 | 1.45 |
Msx2 |
msh homeobox 2 |
2821 |
0.27 |
chr11_35873783_35874348 | 1.45 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
1647 |
0.4 |
chr10_88885537_88886772 | 1.45 |
Slc5a8 |
solute carrier family 5 (iodide transporter), member 8 |
162 |
0.96 |
chr4_124893834_124895373 | 1.45 |
1700125G02Rik |
RIKEN cDNA 1700125G02 gene |
179 |
0.9 |
chr6_94464400_94464793 | 1.45 |
Gm44315 |
predicted gene, 44315 |
19802 |
0.18 |
chr9_99993983_99995346 | 1.44 |
4930519F24Rik |
RIKEN cDNA 4930519F24 gene |
27636 |
0.17 |
chr7_40900053_40900204 | 1.43 |
Vstm2b |
V-set and transmembrane domain containing 2B |
1 |
0.94 |
chr14_79773410_79774519 | 1.43 |
Pcdh8 |
protocadherin 8 |
2652 |
0.21 |
chr8_46295772_46297127 | 1.43 |
Helt |
helt bHLH transcription factor |
1778 |
0.2 |
chr8_112570000_112570856 | 1.42 |
Cntnap4 |
contactin associated protein-like 4 |
373 |
0.76 |
chr4_105170584_105171640 | 1.42 |
Plpp3 |
phospholipid phosphatase 3 |
13765 |
0.26 |
chr6_145047358_145048434 | 1.42 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
43 |
0.82 |
chr4_143296771_143297746 | 1.42 |
Pdpn |
podoplanin |
2205 |
0.26 |
chr3_82547675_82549001 | 1.42 |
Npy2r |
neuropeptide Y receptor Y2 |
254 |
0.94 |
chr5_112215410_112216373 | 1.42 |
Gm26953 |
predicted gene, 26953 |
430 |
0.76 |
chr10_43170789_43171628 | 1.42 |
Gm29246 |
predicted gene 29246 |
2055 |
0.23 |
chr9_106456260_106457377 | 1.42 |
Pcbp4 |
poly(rC) binding protein 4 |
721 |
0.42 |
chr9_41582824_41584205 | 1.41 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr7_75308076_75309218 | 1.41 |
1500012K07Rik |
RIKEN cDNA 1500012K07 gene |
49 |
0.78 |
chr10_23345710_23346907 | 1.41 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
3579 |
0.36 |
chr11_69558079_69558465 | 1.41 |
Efnb3 |
ephrin B3 |
1933 |
0.15 |
chr12_49389021_49389211 | 1.41 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
536 |
0.68 |
chr12_27064608_27065073 | 1.40 |
Gm9866 |
predicted gene 9866 |
50155 |
0.18 |
chr12_44337922_44338660 | 1.40 |
Nrcam |
neuronal cell adhesion molecule |
9041 |
0.18 |
chr1_65311039_65312195 | 1.40 |
Pth2r |
parathyroid hormone 2 receptor |
360 |
0.89 |
chr13_99899939_99901204 | 1.40 |
Cartpt |
CART prepropeptide |
70 |
0.98 |
chr14_61056252_61057429 | 1.40 |
Gm41168 |
predicted gene, 41168 |
6587 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 10.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.9 | 2.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.9 | 2.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.9 | 2.7 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.9 | 2.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.8 | 2.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.8 | 1.6 | GO:0048880 | sensory system development(GO:0048880) |
0.8 | 4.1 | GO:0021764 | amygdala development(GO:0021764) |
0.8 | 4.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.7 | 0.7 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.7 | 4.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.7 | 8.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.7 | 2.6 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.6 | 5.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 2.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.6 | 2.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 4.9 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.6 | 1.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.6 | 1.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.6 | 6.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.5 | 0.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.5 | 1.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 1.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.5 | 2.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.5 | 2.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 4.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 4.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 2.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 2.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.5 | 1.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 0.5 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.5 | 1.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 0.5 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.5 | 1.4 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.4 | 1.3 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.4 | 1.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 1.3 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.4 | 2.1 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.4 | 1.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 2.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.4 | 1.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 0.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.4 | 1.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.4 | 1.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 1.4 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.4 | 1.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 1.1 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 5.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 2.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.3 | 3.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 2.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 1.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 0.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.3 | 1.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 1.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.3 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 5.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 2.4 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.3 | 0.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 1.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 0.9 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 1.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 1.1 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 1.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 1.1 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.3 | 1.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.3 | 1.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 0.8 | GO:0098597 | observational learning(GO:0098597) |
0.3 | 1.4 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.3 | 1.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 0.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 0.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 0.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.3 | 0.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 0.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 1.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 1.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.5 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 0.5 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.2 | 0.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.2 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.7 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 0.5 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 1.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 3.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 5.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.9 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 1.8 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 2.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.2 | 0.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 0.7 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 1.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.4 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 1.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.2 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 1.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 0.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 1.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 0.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.8 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 0.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 0.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 1.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 0.9 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.4 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.2 | 0.2 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 0.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 0.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 1.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.4 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 2.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 0.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 1.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 1.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.2 | 0.7 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 0.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 1.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 1.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.3 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.2 | 0.9 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 1.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 1.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 0.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.5 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.2 | 3.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 3.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.2 | 0.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 0.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 13.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 1.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.2 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.9 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.7 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 0.1 | GO:0035482 | gastric motility(GO:0035482) |
0.1 | 4.8 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 1.9 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.4 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 1.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.7 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.9 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 2.0 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 1.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 1.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 3.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 1.5 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.5 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.6 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 1.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.5 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.2 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 2.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 1.9 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 | 0.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.3 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.8 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.9 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 1.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 1.2 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 2.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 1.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.5 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.6 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 0.1 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.9 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.4 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 3.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.2 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 2.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.4 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.5 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.4 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.3 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 1.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.2 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.7 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 1.1 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.1 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.1 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.1 | 0.1 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.1 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.3 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.1 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.1 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 1.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 1.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.2 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 1.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 1.8 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.4 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 1.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.5 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.3 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.1 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.2 | GO:0043380 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
0.1 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.3 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.1 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.4 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.7 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.1 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 1.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.2 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.2 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.1 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 1.5 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.2 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.5 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.1 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.2 | GO:0060026 | convergent extension(GO:0060026) |
0.1 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.3 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.1 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 1.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.0 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.0 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.0 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.1 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
0.0 | 0.0 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.0 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.3 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.1 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.0 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.0 | 0.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.0 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.0 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.2 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.0 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.6 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.2 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.4 | GO:0001736 | establishment of planar polarity(GO:0001736) |
0.0 | 0.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 1.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 1.0 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.0 | 0.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.2 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.1 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.6 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.0 | 0.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.7 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.2 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.6 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.0 | 0.5 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.1 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.5 | GO:0050808 | synapse organization(GO:0050808) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0086009 | membrane repolarization(GO:0086009) |
0.0 | 0.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.0 | GO:0003128 | heart field specification(GO:0003128) |
0.0 | 0.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.3 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.6 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.0 | 0.1 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.0 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.0 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.1 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.0 | 0.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.0 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.0 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.0 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.0 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 1.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.0 | 0.0 | GO:2000860 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.8 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.0 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.0 | 0.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 1.4 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.0 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.0 | 0.0 | GO:0002874 | chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.0 | 0.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0014878 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.2 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.1 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.0 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.0 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.0 | 0.4 | GO:1990138 | neuron projection extension(GO:1990138) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.0 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.2 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.0 | 0.0 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.0 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) |
0.0 | 0.0 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0001821 | histamine secretion(GO:0001821) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0090656 | t-circle formation(GO:0090656) |
0.0 | 0.0 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.0 | 0.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.0 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.0 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
0.0 | 0.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.1 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.0 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.0 | 0.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.0 | 0.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.5 | 1.9 | GO:1990696 | USH2 complex(GO:1990696) |
0.4 | 2.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 3.7 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 1.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 2.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 1.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 0.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 1.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 3.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 1.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 2.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 4.6 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 6.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 1.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 5.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 1.1 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 6.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 1.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 0.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 7.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 28.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 1.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 4.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 6.0 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 5.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.5 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 1.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 2.0 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 1.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 1.1 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 1.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 2.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 1.4 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.5 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 1.5 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 3.0 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.3 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 4.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 1.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.0 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.9 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.2 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 3.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.2 | 3.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 2.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 1.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.6 | 1.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.6 | 3.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.5 | 2.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 1.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.5 | 1.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 1.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 1.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.4 | 2.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 1.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 1.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.4 | 2.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 3.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 1.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 1.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 1.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 1.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 5.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 1.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 3.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 1.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 3.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 0.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 3.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.3 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 0.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 1.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 6.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 1.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 0.8 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.7 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 2.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 4.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 1.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 1.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 1.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 5.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.6 | GO:0034806 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 3.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 4.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 4.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 3.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 1.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 1.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 1.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 2.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 3.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 4.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 6.8 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 3.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.4 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 2.7 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.9 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.5 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.5 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 2.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.6 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 2.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 1.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.4 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.3 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 2.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 2.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 1.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 1.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 1.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.3 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.0 | 0.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.0 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 1.5 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 1.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.0 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 5.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 10.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 4.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 8.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 3.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 4.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 7.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 6.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 11.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 3.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 3.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 4.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 0.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.3 | 6.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 2.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 5.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 3.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 0.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 3.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 3.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 1.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 1.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 4.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 5.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 2.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 3.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 2.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 7.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 1.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |